DUBLIN--(BUSINESS WIRE)--The "Global Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
In this report, Global self-injection market is projected to reach USD 52.437.46 million by 2024 from USD 21.950.41 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.
Major factors driving the growth of market are the rising cases of chronic diseases, increasing demand of self-injection devices.
The global self-injection market is segmented on the basis of product type, application, usage pattern, mode of administration, end user, distribution channel and geography:
- On the basis of product type, market is segmented into 4 types, namely, auto injectors, wearable injectors, needle free injectors (NFI), and pen injectors.
- On the basis of application, the global self-injection market is segmented into oncology, hormonal disorders, autoimmune diseases, orphan diseases, and others.
- On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
- Based on distribution channel, market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
- Based on mode of administration, the global self-injection market is segmented into circulatory, organs, skin and central nervous system.
- On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.
Market Dynamics
Drivers
- Rising Cases of Chronic Diseases
- Rising Demand of Self-Injection Devices
- Growth of Biologics Market
- Technological Advancements and Innovations in Drug Delivery Market
Restraints
- High Cost of Development
- Strict Regulatory Framework
Opportunity
- Increasing Demand for Generic and Biosimilar Drugs
- Generics
- Biosimilars
- Increasing Demand for Contraceptive Injectables
- Increasing Demand for Self-Administration of Drugs
Challenges
- Alternative Route of Drug Administration
- Product Recall
- Stability of Products
- Sterility of Injections
Becton, Dickinson and Company is going to dominate the global self-injection market following with, Novo Nordisk, Sanofi and Pfizer, along with others such as:
- Antares Pharma, Bespak
- Gerresheimer AG
- Impax Laboratories, Inc.
- Mylan N.V.
- Sandoz
- Unilife Corporation
- West Pharmaceutical Services, Inc. and
- Ypsomed.
For more information about this report visit https://www.researchandmarkets.com/research/gdl482/global_self
